HUNTSMAN RONALD KIRK (Chairman & CEO) purchased 47.6% of their position (5K shares) of VIVOS THERAPEUTICS, INC. on the open market
Open‑market purchase worth $21.5K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/22/2021ACC: 0001493152-21-023354
DirectorOfficer10% Owner· Chairman & CEO
Since Dec 2020
+5K
Net shares
Net buyer
$21.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5K
Price / share
$4.31
Trade value
$21.55K
% of position
47.6%
9/21/2021
10.50K→15.50K
Total
Net shares
+5K
Net value
$21.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/21/2021 | P · Purchase | +5K | $4.31 | $21.55K | 47.6% | 10.50K | 15.50K |
| Total | +5K | $21.55K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.74M
Total
1.74M indirect1.74M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.74M | Indirect |
| Total | 1.74M | 1.74M indirect |
Derivative Holdings (Post-Transaction)1
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
333.33K
Shares owned
333.33K
Exercise price
1.65
Expiration
—
Exercise window
—
Total
Underlying
333.33K
Owned
333.33K
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 1.65 | — | — | 333.33K | 333.33K |
| Total | 333.33K | 333.33K | ||||